[Expression of THY1 Gene in Epithelial Ovarian Cancer].

Li-qin Zeng,Zhi-lan Peng,Zhen-ling Duan
DOI: https://doi.org/10.3760/cma.j.issn.0253-3766.2009.02.009
2009-01-01
Abstract:OBJECTIVE:To detect the expession of THY1 in ovarian serous cystadenocarcinoma tissues.METHODS:Immunohistochemistry was performed to detect the expression of THY1 gene in formalin-fixed, paraffin-embedded specimens of normal ovaries (n = 25), ovarian serous cystadenoma (n = 25), and serous cystadenocarcinoma (n = 53). The correlation of THY1 expression with clinicopathological parameters was statistically analyzed.RESULTS:The positive expression rates of THY1 protein in normal ovaries, ovarian serous cystadenomas and ovarian serous cystadenocarcinomas were 60.0% (15/25), 72.0% (18/25) and 34.0% (18/53), respectively. The values of IOD of THY1 protein expression were 288,449.2 +/- 60,087.3, 271,655.6 +/- 66,588.7 and 252,087.6 +/- 45,559.4, respectively. The expression of THY1 protein was significantly down-regulated in ovarian serous cystadenocarcinoma tissues compared with that in normal ovarian tissues and ovarian serous cystadenoma tissues (P < 0.05). THY1 expression was negatively correlated with surgical-pathological staging, histological differentiation and lymph node involvement (P < 0.05).CONCLUSION:The decreased level of THY1 expression may be related with the occurrence and development of ovarian serous cystadenocarcinoma.
What problem does this paper attempt to address?